Continued advances in antihypertensive therapy

Norman M Kaplan

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Treatment of hypertension with diuretics and adrenergic inhibitors according to a stepped-care approach has been found to reduce the incidence of stroke but to have an insignificant effect on the occurrence of coronary heart disease. The availability of the calcium-channel-blocking agents and angiotensin-converting-enzyme inhibitors led to their inclusion as choices for initial monotherapy in the 1988 report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure, which stressed that hypertension be controlled with the fewest possible drugs at the lowest effective doses. Monotherapy for hypertension generally results in a lower cost, fewer side effects, fewer drug interactions, and greater patient compliance. The use of once-daily sustained-release verapamil at a dose of 180 mg is an example of the successful application of this newer approach to the treatment of mild-to-moderate hypertension.

Original languageEnglish (US)
Pages (from-to)43-48
Number of pages6
JournalCardiovascular Reviews and Reports
Volume13
Issue number5
StatePublished - 1992

Fingerprint

Antihypertensive Agents
Hypertension
Therapeutics
Calcium Channels
Patient Compliance
Verapamil
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Adrenergic Agents
Coronary Disease
Stroke
Costs and Cost Analysis
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Continued advances in antihypertensive therapy. / Kaplan, Norman M.

In: Cardiovascular Reviews and Reports, Vol. 13, No. 5, 1992, p. 43-48.

Research output: Contribution to journalArticle

Kaplan, Norman M. / Continued advances in antihypertensive therapy. In: Cardiovascular Reviews and Reports. 1992 ; Vol. 13, No. 5. pp. 43-48.
@article{eb6638abf70445adbf6bd24476bf04a9,
title = "Continued advances in antihypertensive therapy",
abstract = "Treatment of hypertension with diuretics and adrenergic inhibitors according to a stepped-care approach has been found to reduce the incidence of stroke but to have an insignificant effect on the occurrence of coronary heart disease. The availability of the calcium-channel-blocking agents and angiotensin-converting-enzyme inhibitors led to their inclusion as choices for initial monotherapy in the 1988 report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure, which stressed that hypertension be controlled with the fewest possible drugs at the lowest effective doses. Monotherapy for hypertension generally results in a lower cost, fewer side effects, fewer drug interactions, and greater patient compliance. The use of once-daily sustained-release verapamil at a dose of 180 mg is an example of the successful application of this newer approach to the treatment of mild-to-moderate hypertension.",
author = "Kaplan, {Norman M}",
year = "1992",
language = "English (US)",
volume = "13",
pages = "43--48",
journal = "Cardiovascular Reviews and Reports",
issn = "0197-3118",
publisher = "Le Jacq Communications, Inc.",
number = "5",

}

TY - JOUR

T1 - Continued advances in antihypertensive therapy

AU - Kaplan, Norman M

PY - 1992

Y1 - 1992

N2 - Treatment of hypertension with diuretics and adrenergic inhibitors according to a stepped-care approach has been found to reduce the incidence of stroke but to have an insignificant effect on the occurrence of coronary heart disease. The availability of the calcium-channel-blocking agents and angiotensin-converting-enzyme inhibitors led to their inclusion as choices for initial monotherapy in the 1988 report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure, which stressed that hypertension be controlled with the fewest possible drugs at the lowest effective doses. Monotherapy for hypertension generally results in a lower cost, fewer side effects, fewer drug interactions, and greater patient compliance. The use of once-daily sustained-release verapamil at a dose of 180 mg is an example of the successful application of this newer approach to the treatment of mild-to-moderate hypertension.

AB - Treatment of hypertension with diuretics and adrenergic inhibitors according to a stepped-care approach has been found to reduce the incidence of stroke but to have an insignificant effect on the occurrence of coronary heart disease. The availability of the calcium-channel-blocking agents and angiotensin-converting-enzyme inhibitors led to their inclusion as choices for initial monotherapy in the 1988 report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure, which stressed that hypertension be controlled with the fewest possible drugs at the lowest effective doses. Monotherapy for hypertension generally results in a lower cost, fewer side effects, fewer drug interactions, and greater patient compliance. The use of once-daily sustained-release verapamil at a dose of 180 mg is an example of the successful application of this newer approach to the treatment of mild-to-moderate hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0026752038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026752038&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026752038

VL - 13

SP - 43

EP - 48

JO - Cardiovascular Reviews and Reports

JF - Cardiovascular Reviews and Reports

SN - 0197-3118

IS - 5

ER -